Most cited papers from Central Clinical Hospital

Central Clinical Hospital

What are the most cited papers from Central Clinical Hospital?

The most cited paper from Central Clinical Hospital is "Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial" (Hertzel C. Gerstein et al., 2019), with 3,173 citations. Next come "Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial" (1,861) and "Ticagrelor with or without Aspirin in High-Risk Patients after PCI" (1,040).

Published TypeFieldAccessAuthorsCitations

Showing 50 of 60 papers. Every paper with more than 137 citations is listed.

Most cited papers, sortable by citations and release date
#	Paper
1	Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial Hertzel C. Gerstein et al. · The Lancet Open access1,458 authors	9 Jun 2019	3,173
2	Comparative effectiveness of axitinib versus sorafenib in advanced renal cell carcinoma (AXIS): a randomised phase 3 trial Brian I. Rini et al. · The Lancet	4 Nov 2011	1,861
3	Ticagrelor with or without Aspirin in High-Risk Patients after PCI Roxana Mehran et al. · New England Journal of Medicine Open access	26 Sep 2019	1,040
4	The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial Adriaan A. Voors et al. · Nature Medicine Open access	28 Feb 2022	934
5	Revised ESTS guidelines for preoperative mediastinal lymph node staging for non-small-cell lung cancer Paul De Leyn, Christophe Dooms, J. Kuzdzal et al. · European Journal of Cardio-Thoracic Surgery Open access	26 Feb 2014	846
6	The International Association for the Study of Lung Cancer Lung Cancer Staging Project Hisao Asamura, Kari Chansky, John Crowley et al. · Journal of Thoracic Oncology Open access	4 Sep 2015	723
7	The importance of patient-reported outcomes in clinical trials and strategies for future optimization Rebecca Mercieca‐Bebber, Madeleine Trudy King, Melanie Jane Calvert et al. · Patient Related Outcome Measures Open access	31 Oct 2018	695
8	CD38 is critical for social behaviour by regulating oxytocin secretion Duo Jin et al. · Nature	7 Feb 2007	677
9	Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial Hertzel C. Gerstein et al. · The Lancet Open access1,458 authors	9 Jun 2019	646
10	A Phase 3 Randomized Trial of Nicotinamide for Skin-Cancer Chemoprevention Andrew C. Chen, Andrew James Martin, Bonita Choy et al. · New England Journal of Medicine	22 Oct 2015	644
11	ESTS guidelines for preoperative lymph node staging for non-small cell lung cancer Paul De Leyn, Didier Lardinois, Paul E. Van Schil et al. · European Journal of Cardio-Thoracic Surgery Open access	20 Apr 2007	497
12	Deficiency of Prebiotic Fiber and Insufficient Signaling Through Gut Metabolite-Sensing Receptors Leads to Cardiovascular Disease David M. Kaye et al. · Circulation Open access	18 Mar 2020	420
13	Estrogen receptor β Sebastian A. Lewandowski, Katarzyna B. Kalita, Leszek Kaczmarek · FEBS Letters	10 Jul 2002	380
14	Life and death of liquid-infused surfaces: a review on the choice, analysis and fate of the infused liquid layer Sam Peppou-Chapman, Jun Ki Hong, Anna Waterhouse et al. · Chemical Society Reviews Review	2020	376
15	Inhaled Formoterol Dry Powder Versus Ipratropium Bromide in Chronic Obstructive Pulmonary Disease Ronald Dahl, Louis A.P.M. Greefhorst, Dariusz Nowak et al. · American Journal of Respiratory and Critical Care Medicine	Sep 2001	358
16	Effects of denosumab on fracture and bone mineral density by level of kidney function Sophie A. Jamal, Östen Ljunggren, Catherine O. Stehman‐Breen et al. · Journal of Bone and Mineral Research	13 Apr 2011	357
17	Consolidation Therapy With Low-Dose Thalidomide and Prednisolone Prolongs the Survival of Multiple Myeloma Patients Undergoing a Single Autologous Stem-Cell Transplantation Procedure Andrew G Spencer, Henry Miles Prince, Andrew Warwick Roberts et al. · Journal of Clinical Oncology Open access	10 Mar 2009	337
18	Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers Hanna Gałkowska, Urszula Wojewódzka, Waldemar Lech Olszewski · Wound Repair and Regeneration	Sep 2006	322
19	The identification and management of interstitial lung disease in systemic sclerosis: evidence-based European consensus statements Anna‐Maria Hoffmann‐Vold et al. · The Lancet Rheumatology Open access	14 Jan 2020	309
20	Effect of amiodarone on mortality after myocardial infarction: A double-blind, placebo-controlled, pilot study Leszek Ceremuzyński, Elzbieta Kleczar, Maria Krzemińska‐Pakuła et al. · Journal of the American College of Cardiology Open access	Nov 1992	300
21	Guidelines for Preventing and Treating Vitamin D Deficiency: A 2023 Update in Poland Paweł Płudowski et al. · Nutrients Open access	30 Jan 2023	299
22	Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial Tali Cukierman‐Yaffe et al. · The Lancet Neurology Open access	17 Jun 2020	289
23	Phenotyping Pharyngeal Pathophysiology using Polysomnography in Patients with Obstructive Sleep Apnea Scott A. Sands, Bradley A. Edwards, Philip Ian Terrill et al. · American Journal of Respiratory and Critical Care Medicine Open access	12 Jan 2018	285
24	Fecal Microbiota Transplantation in Patients With Blood Disorders Inhibits Gut Colonization With Antibiotic-Resistant Bacteria: Results of a Prospective, Single-Center Study Jarosław Biliński, Paweł Grzesiowski, Nikolaj Sørensen et al. · Clinical Infectious Diseases Open access	18 Mar 2017	272
25	Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study Timothy J. Iveson, Ross C. Donehower, Ірина Давиденко et al. · The Lancet Oncology	22 Jun 2014	266
26	Deep Remission at 1 Year Prevents Progression of Early Crohn’s Disease Ryan C. Ungaro et al. · Gastroenterology Open access	26 Mar 2020	244
27	Evolution and epidemiology of extended-spectrum β-lactamases (ESBLs) and ESBL-producing microorganisms Marek Gniadkowski · Clinical Microbiology and Infection Open access	Nov 2001	238
28	State of the art paper Urinary tract infections in pregnancy: old and new unresolved diagnostic and therapeutic problems Joanna Matuszkiewicz‐Rowińska, Jolanta Małyszko, Monika Wieliczko · Archives of Medical Science Open access	2015	233
29	Usefulness of Diagnostic Criteria of Tuberous Sclerosis Complex in Pediatric Patients Sergiusz Jóźwiak, Robert Allen Schwartz, Camila Krysicka Janniger et al. · Journal of Child Neurology	Oct 2000	225
30	Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension Chantal Mathieu, Priscilla A. Hollander, Bresta Miranda-Palma et al. · The Journal of Clinical Endocrinology & Metabolism Open access	8 Feb 2013	219
31	A Polymorphism in the P2X7 Gene Increases Susceptibility to Extrapulmonary Tuberculosis Suran Loshana Fernando, Bernadette M. Saunders, Ronald Sluyter et al. · American Journal of Respiratory and Critical Care Medicine	9 Nov 2006	205
32	Standard Terms, Definitions, and Policies for Minimally Invasive Resection of Thymoma Alper Toker, Joshua R. Sonett, Marcin Zieliński et al. · Journal of Thoracic Oncology Open access	15 Jun 2011	194
33	The review of versatile application of collagen Alina Sionkowska, Sławomir Skrzyński, Krzysztof Śmiechowski et al. · Polymers for Advanced Technologies	6 Jun 2016	191
34	Design and baseline characteristics of participants in the R esearching cardiovascular E vents with a W eekly IN cretin in D iabetes ( REWIND ) trial on the cardiovascular effects of dulaglutide Hertzel C. Gerstein et al. · Diabetes Obesity and Metabolism Open access	2 Jun 2017	188
35	Optic Pathway Gliomas in Children With and Without Neurofibromatosis 1 Elżbieta Czyżyk, Sergiusz Jóźwiak, Marcin Roszkowski et al. · Journal of Child Neurology	Jul 2003	188
36	Management of tricuspid valve regurgitation Manuel Jesus Antunes, José Fernando Rodríguez-Palomares, Bernard Prendergast et al. · European Journal of Cardio-Thoracic Surgery Open access	20 Jul 2017	187
37	Ticagrelor alone vs. ticagrelor plus aspirin following percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: TWILIGHT-ACS Usman Baber et al. · European Heart Journal Open access	4 Aug 2020	185
38	Mechanisms of the Epithelial–Mesenchymal Transition and Tumor Microenvironment in Helicobacter pylori-Induced Gastric Cancer Jacek Baj, Izabela Korona‐Głowniak, Alicja Forma et al. · Cells Open access	23 Apr 2020	180
39	Gastrointestinal ultrasound in inflammatory bowel disease: an underused resource with potential paradigm-changing application Robert Venning Bryant, Antony B. Friedman, Emily Kate Wright et al. · Gut	3 Feb 2018	180
40	Avascular Necrosis of Femoral Head—Overview and Current State of the Art Wojciech Konarski, Tomasz Poboży, Andrzej M. Śliwczyński et al. · International Journal of Environmental Research and Public Health Open access	15 Jun 2022	179
41	Peri-intubation Cardiovascular Collapse in Patients Who Are Critically Ill: Insights from the INTUBE Study Vincenzo Russotto, Elena Tassistro, Sheila Nainan Myatra et al. · American Journal of Respiratory and Critical Care Medicine Open access	10 May 2022	179
42	Efficacy of radionuclide treatment DOTATATE Y-90 in patients with progressive metastatic gastroenteropancreatic neuroendocrine carcinomas (GEP-NETs): a phase II study Jarosław Bogdan Ćwikła, A Sankowski, Nina Seklecka et al. · Annals of Oncology Open access	16 Oct 2009	174
43	Secondary autoimmune diseases occurring after HSCT for an autoimmune disease: a retrospective study of the EBMT Autoimmune Disease Working Party Thomas D. Daikeler et al. · Blood Open access	20 May 2011	174
44	Results of a randomized, double‐blind study of romiplostim versus placebo in patients with low/intermediate‐1–risk myelodysplastic syndrome and thrombocytopenia Aristoteles A. N. Giagounidis, Ghulam J. Mufti, Pierre Fenaux et al. · Cancer Open access	4 Apr 2014	174
45	Validation of the Joensuu risk criteria for primary resectable gastrointestinal stromal tumour – The impact of tumour rupture on patient outcomes Piotr Lukasz Rutkowski, Elżbieta Bylina, Agnieszka Woźniak et al. · European Journal of Surgical Oncology	9 Jul 2011	172
46	COVID-19 and ECMO: the interplay between coagulation and inflammation—a narrative review Mariusz Kowalewski, Dario Fina, Artur Słomka et al. · Critical Care ReviewOpen access	8 May 2020	171
47	Systemic sclerosis – multidisciplinary disease: clinical features and treatment Piotr K. Sobolewski, Maria Maślińska, Marta Wieczorek et al. · Reumatologia/Rheumatology Open access	31 Aug 2019	170
48	Serum thymus and activation‐regulated chemokine, macrophage‐derived chemokine and eotaxin as markers of severity of atopic dermatitis Karina Jahnz‐Różyk, Tomasz Targowski, Elwira Beata Paluchowska et al. · Allergy	6 Apr 2005	169
49	Comma hairs: A dermatoscopic marker for tinea capitis Monika Słowińska, Lidia Rudnicka, Robert Allen Schwartz et al. · Journal of the American Academy of Dermatology	17 Oct 2008	166
50	Meta-Analysis of Peripheral or Central Extracorporeal Membrane Oxygenation in Postcardiotomy and Non-Postcardiotomy Shock Giuseppe Maria Raffa, Mariusz Kowalewski, Daniel Brodie et al. · The Annals of Thoracic Surgery ReviewOpen access	27 Jun 2018	160

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.